BlackRock discloses stake in Mural Oncology

Published 02/06/2025, 15:24
BlackRock discloses stake in Mural Oncology

LONDON - Investment management firm BlackRock (NYSE:BLK), Inc. has disclosed a 1.53% stake in Mural Oncology plc, according to a regulatory filing with the Irish Takeover Panel. The position, which comprises 265,889 ordinary shares, was held as of May 30, 2025.

The disclosure was made under Rule 8.3 of the Irish Takeover Panel Act, 1997, Takeover Rules, 2022, which requires that any person with an interest in relevant securities representing 1% or more must report their position in the context of a takeover. No short positions were reported by BlackRock in the filing.

Additionally, the filing included a reference to a stock on loan transaction involving 17,800 ordinary shares of Mural Oncology. No further details were provided regarding this transaction.

BlackRock’s disclosure does not indicate any dealings in cash-settled derivatives or stock-settled derivatives related to Mural Oncology’s securities. The filing also stated that there are no indemnity or option arrangements, or any agreements or understandings relating to the voting rights of any relevant securities under any option that could be an inducement to deal or refrain from dealing.

This information, based on a press release statement, is significant for investors and the market as it reflects BlackRock’s investment position in Mural Oncology. The disclosure is a routine compliance measure and does not necessarily suggest any further action by BlackRock regarding Mural Oncology.

Mural Oncology plc has not commented on the disclosure, and the filing did not indicate any intent by BlackRock regarding its stake in the company.

The news service of the London Stock Exchange (LON:LSEG), RNS, provided this information. BlackRock’s contact for the disclosure was listed as Jana Blumenstein, with a contact number for additional inquiries.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.